Prediction for Bronchopulmonary Dysplasia - Trial NCT05181319
Access comprehensive clinical trial information for NCT05181319 through Pure Global AI's free database. This phase not specified trial is sponsored by Kai Mu and is currently Recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 5000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Kai Mu
Qianfoshan Hospital
Timeline & Enrollment
N/A
Jan 01, 2018
Dec 01, 2022
Primary Outcome
bronchopulmonary dysplasia occurs
Summary
In this Multi-center study performed from January 2018, we reviewed data on infants whose
 gestational ages were below 36 weeks. we collected data containing maternal diseases and
 neonatal clinical features. LASSO regression was used to select variables for the risk model.
 Then, we used multivariable logistic regression to build the prediction model incorporating
 these selected features. Discrimination was assessed by the C-index, and and calibration of
 the model was assessed by and calibration curve and the Hosmer-Lemeshow test.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05181319
Non-Device Trial